The most commonly applied models of diabetes involve STZ treatment that evoke compromised glycemic homeostasis and thus represent a model of type 1 diabetes resulting from decreased insulin secretion due to gradual pancreatic beta-cell death. This evidence concerns the gene INS and diabetes mellitus.